ArticleJournal of cellular and molecular medicine2020

Melatonin synergizes BRAF-targeting agent dabrafenib for the treatment of anaplastic thyroid cancer by inhibiting AKT/hTERT signalling.

Yina Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.